News | March 02, 2009

A 209-Patient Study Shows Xpress3.Cardiac Three-Minute SPECT Imaging is Equivalent to Full-Time OSEM, FBP

Stress images: top row, images acquired with quarter-time protocol and processed by WBR bottom row, images acquired with full-time protocol and processed with FBP, with all other acquisition and dose parameters identical.

March 2, 2009 - Results were released today from a clinical study of the quarter-time Xpress3.Cardiac, UltraSPECT's WBR (wide-beam reconstruction) image reconstruction algorithm used to create half-time SPECT images of high diagnostic quality.

The study was conducted in the Division of Nuclear Medicine, Department of Radiology, St.-Luke’s-Roosevelt Hospital in New York It was conducted by a group of researchers led by Dr. DePuey, M.D., director of nuclear medicine at St. Luke’s-Roosevelt and professor of radiology at Columbia University.

“For perfusion SPECT, quarter-time WBR affords image quality, defect characterization, and functional assessment equivalent to full-time OSEM, providing the potential for decreased SPECT acquisition times and/or decreased radiopharmaceutical doses,” said Dr. DePuey. “However, users should be aware of the differences between the various methods when reporting functional results; compared to full-time gated SPECT, quarter-time gated WBR yields significantly lower LVEF's.”

Since the introduction of the half-time Xpress.Cardiac in 2005, UltraSPECT's WBR image reconstruction algorithm has been in routine clinical use for nuclear cardiology, producing half-time SPECT images of high diagnostic quality. WBR incorporates simultaneous resolution recovery and noise control during reconstruction without applying a post-processing filter. The purpose of the current study was to clinically evaluate the more recently introduced Xpress3.Cardiac product for quarter-time imaging, and determine whether this image acquisition protocol processed by the WBR algorithm optimized for quarter-time SPECT produced adequate imaging outcomes.

The study used the optimized algorithm, in which 209 patients (91 men, 118 women, mean chest circumference = 40 inches) were imaged at rest and stress (dosage: 9 and 32 mCi99 Tc-sestamibi, respectively), first full-time using OSEM (and FBP), and then quarter-time with the new optimized WBR algorithm. Full-time rest scans were acquired in just over 14 minutes (180 degree arc covered by 64 stops at 25 seconds per stop (sps) with a 90 degree, angled, dual-headed detector), while full-time gated (eight frames per cardiac cycle) post-stress scans were performed at 20 sps. Each of these tests were immediately followed by their quarter-time counterparts: rest (6 sps) and post-stress (4 sps) gated SPECT. Blinded observers graded scan quality (1 = poor to 5 = excellent) based on myocardial uniformity, endocardial/epicardial edge definition, and background noise. Perfusion defects were scored using a 17-segment model. In addition, three different commercially available software methods were used to calculate EDV, ESV, and LVEF, Dr. DePuey said.

The results of the study showed that for rest studies, the mean image quality for quarter-time WBR was equivalent to those of full-time OSEM and full-time FBP. For stress, quarter-time WBR quality was actually superior to full-time OSEM. In patients with chest circumferences greater than 44 inches, a longer, 10 sps WBR acquisition improved resting image quality, researchers said. Mean SSSs, SRSs, and SDSs were not significantly different with quarter-time WBR vs. full-time OSEM or FBP.

As for the quantitative analysis of LV volume and function, all three software methods employed showed a good correlation between LVEF, EDV, and ESV as determined by WBR vs. OSEM, although ESV's were generally higher with WBR, primarily due to better delineation of the valve plane at end-systole; EDV's, however, were similar. Thus, EF's were significantly lower with WBR, the study concluded.

For more information visit our website: www.ultraspect.com

Related Content

Breast Cancer Follow-up Imaging Varies Widely
News | Breast Imaging | July 13, 2018
July 13, 2018 — Follow-up imaging for women...
Lack of Insurance Coverage Delaying Proton Therapy Clinical Trials
News | Proton Therapy | July 12, 2018
Randomized clinical trials are the gold standard of cancer research and can shed light on whether innovative, new...
Breast Cancer Studies Ignore Race, Socioeconomic Factors
News | Women's Health | July 11, 2018
A new commentary appearing in the July issue of Cancer Causes & Control points to evidence that social factors help...
High-Strength MRI May Release Mercury from Amalgam Dental Fillings
News | Magnetic Resonance Imaging (MRI) | July 05, 2018
Exposure to ultra-high-strength magnetic resonance imaging (MRI) may release toxic mercury from amalgam fillings in...
Researcher Investigates Eliminating Radiation for HER2-Positive Breast Cancer
News | Radiation Therapy | July 02, 2018
Researchers at The University of Kansas Cancer Center have launched a clinical trial that eliminates radiation from the...
Norwegian Study Confirms Higher Cancer Rate in Women with Dense Breast Tissue
News | Breast Density | July 02, 2018
A large Norwegian study using automated breast density measurements found that women with mammographically dense breast...
SNMMI Image of the Year Highlights Theranostic Approach for Advanced Prostate Cancer

IMAGE OF THE YEAR: PSMA PET before and after lutetium-177 PSMA617 theranostics in 8 patients with metastatic prostate cancer who exhausted standard therapeutic options.

68Ga-PSMA11 PET maximum intensity projection (MIP) images at baseline and 3 months after 177Lu-PSMA617 in 8 patients with PSA decline ≥ 98 percent in a prospective phase II study. Any disease with SUV over 3 is in red. Credit: Michael Hofman, John Violet, Shahneen Sandhu, Justin Ferdinandus, Amir Iravani, Grace Kong, Aravind Ravi Kumar, Tim Akhurst, Sue Ping Thang, Price Jackson, Mark Scalzo, Scott Williams and Rodney Hicks, Peter MacCallum Cancer Centre, Melbourne, Australia.

News | PET Imaging | June 29, 2018
In the battle against metastatic castrate-resistant prostate cancer, studies have demonstrated a high response rate to...
MILabs Introduces Futuristic PET Capabilities on New VECTor6 System
Technology | PET Imaging | June 28, 2018
At the 2018 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, June 23-26, in Philadelphia,...
EchoMD AutoEF Software Improves Variability in Ejection Fraction Estimation
News | Cardiovascular Ultrasound | June 27, 2018
A recent study conducted with the Minneapolis Heart Institute found that Bay Labs’ EchoMD AutoEF deep learning software...
Overlay Init